Arcturus Therapeutics Holdings Inc (ARCT)
16.91
-0.16
(-0.94%)
USD |
NASDAQ |
Nov 22, 16:00
16.94
+0.03
(+0.18%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Revenue (Annual): 157.75M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 157.75M |
| December 31, 2022 | 205.76M |
| December 31, 2021 | 12.36M |
| December 31, 2020 | 9.539M |
| December 31, 2019 | 20.79M |
| Date | Value |
|---|---|
| December 31, 2018 | 15.75M |
| December 31, 2017 | 13.00M |
| December 31, 2016 | 20.38M |
| December 31, 2015 | 6.138M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
9.539M
Minimum
2020
205.76M
Maximum
2022
81.24M
Average
20.79M
Median
2019
Revenue (Annual) Benchmarks
| Bioventus Inc | 512.34M |
| Fulcrum Therapeutics Inc | 2.805M |
| Pfizer Inc | 58.50B |
| AIM ImmunoTech Inc | 0.202M |
| Protalix BioTherapeutics Inc | 65.49M |